These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 31397487)

  • 1. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Serruys PW; Takahashi K; Chichareon P; Kogame N; Tomaniak M; Modolo R; Chang CC; Komiyama H; Soliman O; Wykrzykowska JJ; de Winter RJ; Ferrario M; Dominici M; Buszman P; Bolognese L; Tumscitz C; Benit E; Stoll HP; Hamm C; Steg PG; Onuma Y; Jüni P; Windecker S; Vranckx P; Colombo A; Valgimigli M
    Eur Heart J; 2019 Aug; 40(31):2595-2604. PubMed ID: 31397487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
    Gao C; Tomaniak M; Takahashi K; Kawashima H; Wang R; Hara H; Ono M; Montalescot G; Garg S; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; van Geuns RJ; Hamm C; Steg PG; Onuma Y; Angiolillo DJ; Serruys PW
    Cardiovasc Diabetol; 2020 Oct; 19(1):179. PubMed ID: 33066794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.
    Takahashi K; Serruys PW; Chichareon P; Chang CC; Tomaniak M; Modolo R; Kogame N; Magro M; Chowdhary S; Eitel I; Zweiker R; Ong P; Ottesen MM; Tijssen JGP; Wykrzykowska JJ; de Winter RJ; Garg S; Stoll HP; Hamm C; Steg PG; Onuma Y; Valgimigli M; Vranckx P; Carrie D; Windecker S
    J Am Coll Cardiol; 2019 Oct; 74(16):2015-2027. PubMed ID: 31623758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
    Kogame N; Chichareon P; De Wilder K; Takahashi K; Modolo R; Chang CC; Tomaniak M; Komiyama H; Chieffo A; Colombo A; Garg S; Louvard Y; Jüni P; G Steg P; Hamm C; Vranckx P; Valgimigli M; Windecker S; Stoll HP; Onuma Y; Janssens L; Serruys PW
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):100-111. PubMed ID: 31410968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
    Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
    Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Ge Z; Kan J; Gao X; Raza A; Zhang JJ; Mohydin BS; Gao F; Shao Y; Wang Y; Zeng H; Li F; Khan HS; Mengal N; Cong H; Wang M; Chen L; Wei Y; Chen F; Stone GW; Chen SL;
    Lancet; 2024 May; 403(10439):1866-1878. PubMed ID: 38599220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).
    Kawashima H; Tomaniak M; Ono M; Wang R; Hara H; Gao C; Takahashi K; Sharif F; Thury A; Suryapranata H; Walsh S; Cotton J; Carrie D; Sabate M; Steinwender C; Leibundgut G; Wykrzykowska J; de Winter RJ; Garg S; Hamm C; Steg PG; Jüni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW
    Am J Cardiol; 2021 Jan; 138():1-10. PubMed ID: 33065080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial.
    Tomaniak M; Chichareon P; Modolo R; Takahashi K; Chang CC; Kogame N; Spitzer E; Buszman PE; van Geuns RM; Valkov V; Steinwender C; Geisler T; Prokopczuk J; Sabaté M; Zmudka K; Rademaker-Havinga T; Tijssen JGP; Jüni P; Hamm C; Steg PG; Onuma Y; Vranckx P; Valgimigli M; Windecker S; Baber U; Anderson R; Dominici M; Serruys PW
    EuroIntervention; 2020 Apr; 15(18):e1605-e1614. PubMed ID: 31845894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
    Kim BK; Hong SJ; Cho YH; Yun KH; Kim YH; Suh Y; Cho JY; Her AY; Cho S; Jeon DW; Yoo SY; Cho DK; Hong BK; Kwon H; Ahn CM; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
    JAMA; 2020 Jun; 323(23):2407-2416. PubMed ID: 32543684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
    Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
    Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.
    Chichareon P; Modolo R; Kerkmeijer L; Tomaniak M; Kogame N; Takahashi K; Chang CC; Komiyama H; Moccetti T; Talwar S; Colombo A; Maillard L; Barlis P; Wykrzykowska J; Piek JJ; Garg S; Hamm C; Steg PG; Jüni P; Valgimigli M; Windecker S; Onuma Y; Mehran R; Serruys PW
    JAMA Cardiol; 2020 Jan; 5(1):21-29. PubMed ID: 31693078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial.
    Serruys PW; Tomaniak M; Chichareon P; Modolo R; Kogame N; Takahashi K; Chang CC; Spitzer E; Walsh SJ; Adlam D; Hildick-Smith D; Édes I; van de Harst P; Krackhardt F; Tijssen JGP; Rademaker-Havinga T; Garg S; Steg PG; Hamm C; Jüni P; Vranckx P; Onuma Y; Verheugt FWA
    EuroIntervention; 2019 Dec; 15(12):e1090-e1098. PubMed ID: 30888959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial.
    Vranckx P; Valgimigli M; Windecker S; Steg PG; Hamm C; Jüni P; Garcia-Garcia HM; van Es GA; Serruys PW
    EuroIntervention; 2016 Nov; 12(10):1239-1245. PubMed ID: 26606735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: TICO trial rationale and design.
    Kim C; Hong SJ; Shin DH; Kim BK; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Am Heart J; 2019 Jun; 212():45-52. PubMed ID: 30933857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events.
    Hara H; van Klaveren D; Takahashi K; Kogame N; Chichareon P; Modolo R; Tomaniak M; Ono M; Kawashima H; Wang R; Gao C; Niethammer M; Fontos G; Angioi M; Ribeiro VG; Barbato E; Leandro S; Hamm C; Valgimigli M; Windecker S; Jüni P; Steg PG; Verbeeck J; Tijssen JGP; Sharif F; Onuma Y; Serruys PW;
    Circ Cardiovasc Qual Outcomes; 2020 Aug; 13(8):e006660. PubMed ID: 32762446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor With or Without Aspirin After Complex PCI.
    Dangas G; Baber U; Sharma S; Giustino G; Mehta S; Cohen DJ; Angiolillo DJ; Sartori S; Chandiramani R; Briguori C; Dudek D; Escaned J; Huber K; Collier T; Kornowski R; Kunadian V; Kaul U; Oldroyd K; Sardella G; Shlofmitz R; Witzenbichler B; Ya-Ling H; Pocock S; Gibson CM; Mehran R
    J Am Coll Cardiol; 2020 May; 75(19):2414-2424. PubMed ID: 32240761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
    Valgimigli M; Smits PC; Frigoli E; Bongiovanni D; Tijssen J; Hovasse T; Mafragi A; Ruifrok WT; Karageorgiev D; Aminian A; Garducci S; Merkely B; Routledge H; Ando K; Diaz Fernandez JF; Cuisset T; Nesa Malik FT; Halabi M; Belle L; Din J; Beygui F; Abhyankar A; Reczuch K; Pedrazzini G; Heg D; Vranckx P;
    Eur Heart J; 2022 Sep; 43(33):3100-3114. PubMed ID: 35580836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial.
    Gamal AS; Hara H; Tomaniak M; Lunardi M; Gao C; Ono M; Kawashima H; Jüni P; Vranckx P; Windecker S; Hamm C; Steg PG; Onuma Y; Serruys PW
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):756-773. PubMed ID: 34212187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial.
    Takahashi K; Wang R; Kawashima H; Tomaniak M; Gao C; Ono M; Hara H; Wykrzykowska JJ; de Winter RJ; Werner N; Teiger E; Almeida M; Barraud P; Lantelme P; Barlis P; Garg S; Hamm C; Steg PG; Onuma Y; Vranckx P; Windecker S; Valgimigli M; Serruys PW
    Int J Cardiol; 2020 Dec; 320():27-34. PubMed ID: 32750393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.
    Ono M; Hara H; Kawashima H; Gao C; Wang R; Wykrzykowska JJ; Piek JJ; Garg S; Hamm C; Steg PG; Valgimigli M; Windecker S; Vranckx P; Onuma Y; Serruys PW
    EuroIntervention; 2022 Aug; 18(5):e377-e388. PubMed ID: 35260381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.